New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by transplantation of a person’s own blood-forming stem cells can induce sustained remission of relapsing-remitting multiple sclerosis (MS), an autoimmune disease in which the immune system attacks the central nervous system. Read on.

We’re urging them to scrap plans to introduce ‘mandatory activity’ for people in the support group of Employment and Support Allowance (ESA). These plans could force people, already assessed as too unwell to work, to prepare for work or risk facing cuts to their benefits.  Read on.

HSCT could have long-term benefits for some people with MS, according to the results of a large study that we co-funded.

After five years, progression had stopped in just under half of the 239 people eligible for the treatment.  Read on.

Disabled people will get a fresh chance to make their concerns heard as consumers, thanks to a government initiative to be announced on Tuesday.

Eleven sector champions are being appointed to help make different areas of business more accountable to the disabled.  Read on.

RIVERSIDE, Calif. – Multiple sclerosis (MS) is an autoimmune disease of the central nervous system that affects nearly 2.3 million people worldwide. MS is triggered when the immune system attacks the protective covering around nerve fibers, called the myelin sheath. The “demyelination” that follows damages nerve cells and causes impaired exchange of information between the brain and body as well as within the brain itself.  Read on.

Sense of Smell, Women, Biomarkers and More.  Read on.